Lusitropic and anti-hypertrophic effects of the sphingosine-1-phosphate receptor modulator, FTY720, in hypertrophic cardiomyopathy

被引：0
|
作者：
Ryba, D. M. [1 ,2 ]
Warren, C. M. [1 ,2 ]
Karam, C. N. [1 ,2 ]
Davis, R. T., III [1 ,2 ]
Chowdhury, S. A. K. [1 ,2 ]
Alvarez, M. G. [1 ,2 ]
Wieczorek, D. F. [3 ]
Solaro, R. J. [1 ,2 ]
Wolska, B. M. [1 ,2 ,4 ]
机构：
[1] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL USA
[2] Univ Illinois, Coll Med, Ctr Cardiovasc Res, Chicago, IL USA
[3] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH USA
[4] Univ Illinois, Dept Med, Cardiol Sect, Chicago, IL USA
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2017年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
32
引用
下载
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [21] The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis
    Sui, Manshu
    Zhou, Jin
    Xie, Rujuan
    Liu, Xiaogang
    Mu, Suhong
    Jia, Xibei
    Ma, Jing
    Wu, Hongchi
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (01) : 389 - 397
  • [22] Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis
    Mehling, M.
    Johnson, T. A.
    Antel, J.
    Kappos, L.
    Bar-Or, A.
    NEUROLOGY, 2011, 76 (08) : S20 - S27
  • [23] Sphingosine 1-Phosphate Receptor Modulator FTY720 Suppresses Rat Experimental Autoimmune Prostatitis
    Zhang, Z. -Y.
    Zug, C.
    Schluesener, H. J.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011, 73 (06) : 546 - 553
  • [24] Sphingosine-1-Phosphate Receptor Agonist, FTY720, Restores Coronary Flow Reserve in Diabetic Rats
    Xu, Hongzeng
    Jin, Yuanzhe
    Ni, Haifeng
    Hu, Shengda
    Zhang, Qin
    CIRCULATION JOURNAL, 2014, 78 (12) : 2979 - 2986
  • [25] Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo
    Hu, Yinghui
    Lee, Xinhua
    Ji, Benxiu
    Guckian, Kevin
    Apicco, Daniel
    Pepinsky, R. Blake
    Miller, Robert H.
    Mi, Sha
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2011, 48 (01) : 72 - 81
  • [26] Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization
    LaMontagne, K
    Littlewood-Evans, A
    Schnell, C
    O'Reilly, T
    Wyder, L
    Sanchez, T
    Probst, B
    Butler, J
    Wood, A
    Liau, G
    Billy, E
    Theuer, A
    Hla, T
    Wood, J
    CANCER RESEARCH, 2006, 66 (01) : 221 - 231
  • [27] Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis
    Dev, Kumlesh K.
    Mullershausen, Florian
    Mattes, Henri
    Kuhn, Rainer R.
    Bilbe, Graeme
    Hoyer, Daniel
    Mir, Anis
    PHARMACOLOGY & THERAPEUTICS, 2008, 117 (01) : 77 - 93
  • [28] The functional antagonist of sphingosine-1-phosphate, FTY720, impairs gut barrier function
    Sikdar, Sohini
    Mitra, Debmalya
    Das, Oishika
    Bhaumik, Moumita
    Dutta, Shanta
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [29] Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors
    Mullershausen, Florian
    Craveiro, Luis M.
    Shin, Youngah
    Cortes-Cros, Marta
    Bassilana, Frederic
    Osinde, Maribel
    Wisbart, William L.
    Thallmair, Michaela
    Schwab, Martin E.
    Sivasankaran, Rajeev
    Seuwen, Klaus
    Dev, Kumlesh K.
    JOURNAL OF NEUROCHEMISTRY, 2007, 102 (04) : 1151 - 1161
  • [30] The sphingosine-1-phosphate analogue FTY720 is neuroprotective in a rodent model of brain ischemia
    Kim, Hyung-Hwan
    Hwang, Seo-Kyoung
    Shin, Hwa Kyoung
    Blondeau, Nicolas
    You, Zerong
    Liao, James K.
    Waeber, Christian
    STROKE, 2008, 39 (02) : 729 - 729
12345